Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-Esophageal Reflux Disease (GERD) Patients With Night-Time Heartburn Symptoms.

This study has been completed.

Study NCT00553449 Information provided by Janssen-Ortho Inc., Canada

First Received: November 1, 2007 Last Updated: June 16, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2005
Estimated Primary Completion Date:	No date given